KLOW — Peptide Blend
(GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg)

Skin Repair, Inflammation Modulation & Tissue-Regeneration Signaling

KLOW is a multi-peptide research blend formulated to investigate skin regeneration, inflammation modulation, and extracellular matrix (ECM) remodeling.
The blend combines GHK-Cu, BPC-157, TB-500, and KPV—four bioactive peptides widely studied for their complementary roles in cell migration, angiogenesis, immune balance, and tissue repair signaling.

---

Composition

• GHK-Cu (Copper Tripeptide-1)

• BPC-157 (Body Protection Compound)

• TB-500 (Thymosin Beta-4 fragment)

• KPV (Lys–Pro–Val)

---

Mechanistic Overview

GHK-Cu — ECM Remodeling & Skin Signaling

GHK-Cu is a naturally occurring human tripeptide involved in collagen synthesis, elastin organization, and antioxidant defense. Experimental studies show modulation of gene expression related to skin regeneration and firmness.

BPC-157 — Cytoprotection & Tissue Repair

BPC-157 is a gastric-derived peptide investigated for cytoprotective, angiogenic, and anti-inflammatory signaling. It is frequently used in research models of soft-tissue healing, endothelial integrity, and fibroblast migration.

TB-500 — Cell Migration & Angiogenesis

TB-500, a synthetic fragment of thymosin beta-4, is studied for its role in actin regulation, cell motility, and angiogenic pathways, making it a key peptide in wound-healing and tissue-regeneration models.

KPV — Anti-Inflammatory & Immune-Modulating Peptide

KPV (Lys–Pro–Val) is a tripeptide derived from α-melanocyte–stimulating hormone (α-MSH).
Research demonstrates that KPV can modulate NF-κB signaling, reduce pro-inflammatory cytokine expression, and support immune balance in epithelial and skin models—without melanocortin receptor activation.

KPV is commonly studied for:

• Inflammation downregulation

• Skin barrier support

• Redness and irritation signaling pathways

• Gut–skin immune axis research

---

Synergistic Research Rationale

The KLOW blend integrates four complementary biological axes:

• Structural repair & collagen remodeling → GHK-Cu

• Cytoprotection & vascular support → BPC-157

• Cell migration & angiogenesis → TB-500

• Inflammation control & immune balance → KPV

This synergy allows investigation of skin recovery, post-inflammatory repair, and tissue-regeneration signaling in complex experimental models.

---

Primary Experimental Applications

• Skin regeneration and dermal remodeling research

• Inflammatory skin-condition models

• Wound-healing and angiogenesis studies

• ECM turnover and collagen organization

• Barrier repair and post-inflammatory signaling

---

Research Use Only — Important Notice

This KLOW peptide blend is supplied exclusively for laboratory research purposes.

• Not for human or veterinary use

• Not for diagnostic, therapeutic, or cosmetic applications

• Intended only for in vitro research and/or use in appropriately controlled experimental models by qualified professionals

All descriptions above summarize findings from preclinical and mechanistic research and are provided for educational and informational purposes only.

---

References

1. Pickart L., Margolina A.
   Regenerative and protective actions of the GHK-Cu peptide in the skin.
   International Journal of Molecular Sciences, 2018;19(7):1987.
   https://www.mdpi.com/1422-0067/19/7/1987

2. Sikiric P. et al.
   Stable gastric pentadecapeptide BPC-157 and tissue repair mechanisms.
   Current Pharmaceutical Design, 2011;17(16):1612–1632.
   https://pubmed.ncbi.nlm.nih.gov/21524264/

3. Goldstein A.L., Kleinman H.K.
   Thymosin beta-4: actin-sequestering peptide with roles in wound healing and angiogenesis.
   Trends in Molecular Medicine, 2003;9(12):512–518.
   https://pubmed.ncbi.nlm.nih.gov/14604823/

4. Malinda K.M. et al.
   Thymosin beta-4 accelerates wound healing and promotes angiogenesis.
   FASEB Journal, 1999;13(6):755–765.
   https://faseb.onlinelibrary.wiley.com/doi/10.1096/fasebj.13.6.755

5. Catania A. et al.
   The neuropeptide α-MSH in host defense.
   Scientific World Journal, 2010;10:1841–1856.
   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774629/

6. Kannengiesser K. et al.
   Anti-inflammatory properties of the α-MSH-derived tripeptide KPV.
   Journal of Investigative Dermatology, 2008;128(9):2211–2218.
   https://pubmed.ncbi.nlm.nih.gov/18432278/